Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts)

被引：6
作者：
Gupta, S. [1 ]
Climent Duran, M. A. [2 ]
Sridhar, S. [3 ]
Powles, T. B. [4 ]
Bellmunt, J. [5 ]
Tyroller, K. [6 ]
Guenther, S. [7 ]
di Pietro, A. [8 ]
Grivas, P. [9 ]
机构：
[1] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA
[2] Inst Valenciano Oncol, Valencia, Spain
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Queen Mary Univ London, Barts Canc Inst, Expt Canc Med Ctr, St Bartholomews Hosp, London, England
[5] Dana Farber Canc Inst, Harvard Med Sch, Dept Med Oncol, Boston, MA USA
[6] EMD Serono Res & Dev Inst Inc, Billerica, MA USA
[7] Merck Healthcare KGaA, Darmstadt, Germany
[8] Pfizer Srl, Milan, Italy
[9] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2371P
引用
收藏
页码：S1207 / S1207
页数：1
相关论文
共 50 条
[21]   AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF CLINICAL AND GENOMIC SUBGROUPS FROM THE JAVELIN BLADDER 100 TRIAL [J].
Powles, Thomas ;
Petrylak, Daniel P. ;
Park, Se Hoon ;
Sridhar, Srikala S. ;
Caserta, Claudia ;
Thiery-Vuillemin, Antoine ;
Lee, Hyo Jin ;
Bellmunt, Joaquim ;
Yamamoto, Yoshiaki ;
Aragon-Ching, Jeanny B. ;
Huang, Bo ;
Ching, Keith ;
Davis, Craig ;
di Pietro, Alessandra ;
Loriot, Yohann ;
Grivas, Petros .
JOURNAL OF UROLOGY, 2021, 206 :E765-E766
[22]   Long-term outcomes in patients with advanced urothelial carcinoma (UC) who received avelumab first-line (1L) maintenance with or without second-line (2L) treatment: Exploratory analyses from JAVELIN Bladder 100. [J].
Bellmunt, Joaquim ;
Powles, Thomas ;
Duran, Miguel Angel Climent ;
Sridhar, Srikala S. ;
Gurney, Howard ;
Costa, Nuno ;
Di Pietro, Alessandra ;
Huang, Bo ;
Gupta, Shilpa ;
Grivas, Petros .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[23]   Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up from the JAVELIN Bladder 100 trial in subgroups defined by 1L chemotherapy regimen and analysis of overall survival (OS) from start of 1L chemotherapy. [J].
Sridhar, Srikala S. ;
Powles, Thomas ;
Gupta, Shilpa ;
Climent, Miguel Angel ;
Aragon-Ching, Jeanny B. ;
Sternberg, Cora N. ;
Cislo, Paul ;
Costa, Nuno ;
Di Pietro, Alessandra ;
Bellmunt, Joaquim ;
Grivas, Petros .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[24]   Long-term outcomes in patients with advanced urothelial carcinoma (UC) who received avelumab first-line (1 L) maintenance with or without second-line (2 L) treatment: Exploratory analyses from JAVELIN Bladder 100 [J].
Bellmunt, Joaquim ;
Powles, Thomas ;
Duran, Miguel A. Climent ;
Sridhar, Srikala S. ;
Gurney, Howard ;
Pook, David W. ;
Costa, Nuno ;
Di Pietro, Alessandra ;
Huang, Bo ;
Gupta, Shilpa ;
Grivas, Petros .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 :137-138
[25]   AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY [J].
Sridhar, Srikala S. ;
Powles, Thomas ;
Gupta, Shilpa ;
Climent Duran, Miguel A. ;
Aragon-Ching, Jeanny B. ;
Sternberg, Cora N. ;
Cislo, Paul ;
Costa, Nuno ;
Salvo, Porto ;
di Pietro, Alessandra ;
Bellmunt, Joaquim ;
Grivas, Petros .
JOURNAL OF UROLOGY, 2024, 211 (05) :E806-E807
[26]   Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance [J].
Sridhar, Srikala S. ;
Powles, Thomas ;
Duran, Miguel A. Climent ;
Park, Se Hoon ;
Massari, Francesco ;
Thiery-Vuillemin, Antoine ;
Valderrama, Begona P. ;
Ullen, Anders ;
Tsuchiya, Norihiko ;
Aragon-Ching, Jeanny B. ;
Gupta, Shilpa ;
Petrylak, Daniel P. ;
Bellmunt, Joaquim ;
Wang, Jing ;
Laliberte, Robert J. ;
di Pietro, Alessandra ;
Costa, Nuno ;
Grivas, Petros ;
Sternberg, Cora N. ;
Loriot, Yohann .
EUROPEAN UROLOGY, 2024, 85 (02) :154-163
[27]   Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC). [J].
Barthelemy, Philippe ;
Loriot, Yohann ;
Voog, Eric ;
Eymard, Jean Christophe ;
Ravaud, Alain ;
Flechon, Aude ;
Jaillon, Christine Abraham ;
Chasseray, Matthieu ;
Lorgis, Veronique ;
Hilgers, Werner ;
Gobert, AurElien ;
Le Moulec, Sylvestre ;
Simon, Camille ;
Nicolas, Emanuel ;
Escande, Anne ;
Pouessel, Damien ;
Josse, Constant ;
Solbes, Marie-Noelle ;
Lambert, Prisca ;
Thibault, Constance .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[28]   The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma [J].
Hoffman-Censits, Jean ;
Grivas, Petros ;
Powles, Thomas ;
Hawley, Jessica ;
Tyroller, Karin ;
Seeberger, Sonja ;
Guenther, Silke ;
Jacob, Natalia ;
Mehr, Keyvan Tadjalli ;
Hahn, Noah M. .
FUTURE ONCOLOGY, 2024, 20 (04) :179-190
[29]   Avelumab first-line maintenance for advanced urothelial carcinoma: analysis of clinical and genomic subgroups from the phase 3 JAVELIN Bladder 100 trial [J].
Lumba, Sumit ;
Powles, Thomas ;
Petrylak, Daniel P. ;
Park, Se Hoon ;
Sridhar, Srikala S. ;
Caserta, Claudia ;
Thiery-Vuillemin, Antoine ;
Lee, Hyo Jin ;
Bellmunt, Joaquim ;
Yamamoto, Yoshiaki ;
Aragon-Ching, Jeanny B. ;
Huang, Bo ;
Ching, Keith A. ;
Davis, Craig ;
di Pietro, Alessandra ;
Loriot, Yohann ;
Grivas, Petros .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 :44-45
[30]   Avelumab first-line maintenance for advanced urothelial carcinoma: analysis of clinical and genomic subgroups from the phase 3 JAVELIN Bladder 100 trial [J].
Lumba, Sumit ;
Powles, Thomas ;
Petrylak, Daniel P. ;
Park, Se Hoon ;
Sridhar, Srikala S. ;
Caserta, Claudia ;
Thiery-Vuillemin, Antoine ;
Lee, Hyo Jin ;
Bellmunt, Joaquim ;
Yamamoto, Yoshiaki ;
Aragon-Ching, Jeanny B. ;
Huang, Bo ;
Ching, Keith A. ;
Davis, Craig ;
di Pietro, Alessandra ;
Loriot, Yohann ;
Grivas, Petros .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 :126-127
12345